20 articles
New review shows precision biomarkers and biologic drugs are transforming how clinicians select and treat children with persistent cow's milk allergy.
New research reveals how beneficial bacteria help newborn skin develop proper immune responses that protect against chronic inflammation.
A completed Phase 3 trial tests placental MSC secretome injections against placebo in 60 GvHD patients at an Iranian hospital.
Scientists mapped key attack sites on measles virus proteins, finding human antibodies that powerfully neutralize MeV before and after exposure.
GSK's HRV vaccine faces its biggest test yet — can it prevent severe rotavirus gastroenteritis without raising intussusception risk?
New research reveals how our antibodies develop sophisticated defenses against harmful bacteria through repeated childhood infections.
New research reveals how vaccines delivered to mucosal surfaces create stronger, longer-lasting immunity than traditional shots.
A completed French trial investigated whether rogue antibodies targeting ghrelin and alpha-MSH disrupt appetite regulation in eating disorder patients.
A major review maps emerging immunotherapies—from JAK inhibitors to microbiome interventions—that could transform care for celiac and food allergy patients.
Researchers repurpose mRNA-lipid nanoparticle technology to prevent and treat allergic asthma in mice, achieving ~100-fold reduction in airway eosinophils.
Phase 1 trial examines whether vesatolimod can safely stimulate immune response in HIV controllers during treatment interruption.
New research reveals E. coli dominates and suppresses S. aureus in dual-species implant biofilms, with major implications for treating polymicrobial joint infections.
Cutting-edge genomic and immune profiling techniques uncover promising pathways for treating this chronic autoimmune condition.
A new oligonucleotide probe workflow recovers complete RSV and norovirus genomes from low-titer clinical samples, transforming viral surveillance.
New research reveals how lactate triggers lactylation, an epigenetic modification that fuels rheumatoid arthritis and lupus progression.
A new in vitro study shows Thymosin α1 triggers dendritic cells to release IL-15, boosting CD8+ T cell killing and reducing HIV reservoir size.
New research reveals mortality from this rare immune disorder varies by time, potentially improving treatment strategies.
JAMA study reveals promising approach to prevent respiratory syncytial virus hospitalizations in vulnerable newborns.
A randomized trial shows prophylactic obinutuzumab dramatically reduces steroid-requiring cGVHD after bone marrow transplant.
New research reveals the genetic switches that control immune cell development, offering insights into gut health and immunity.
